Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Ekso Bionics Holdings (EKSO) over the last 13 years, with Q3 2025 value amounting to $216000.0.

  • Ekso Bionics Holdings' Change in Account Payables rose 16708.07% to $216000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$152000.0, marking a year-over-year increase of 7831.67%. This contributed to the annual value of -$288000.0 for FY2024, which is 7796.48% up from last year.
  • Latest data reveals that Ekso Bionics Holdings reported Change in Account Payables of $216000.0 as of Q3 2025, which was up 16708.07% from -$565000.0 recorded in Q2 2025.
  • Ekso Bionics Holdings' 5-year Change in Account Payables high stood at $1.8 million for Q4 2021, and its period low was -$882000.0 during Q2 2022.
  • Its 5-year average for Change in Account Payables is $526.32, with a median of -$110000.0 in 2023.
  • Within the past 5 years, the most significant YoY rise in Ekso Bionics Holdings' Change in Account Payables was 128750.0% (2025), while the steepest drop was 32690.76% (2025).
  • Ekso Bionics Holdings' Change in Account Payables (Quarter) stood at $1.8 million in 2021, then plummeted by 66.57% to $602000.0 in 2022, then tumbled by 209.63% to -$660000.0 in 2023, then soared by 62.58% to -$247000.0 in 2024, then skyrocketed by 187.45% to $216000.0 in 2025.
  • Its Change in Account Payables was $216000.0 in Q3 2025, compared to -$565000.0 in Q2 2025 and $444000.0 in Q1 2025.